Showing results (1921-1930 of 2,101) with videos related to
Sort By:
Pageof 211
Molecular Medicine (Cambridge, Mass.)|July 18, 2008
Surface expression of Bcl-2 in chronic lymphocytic leukemia and other B-cell leukemias and lymphomas without a breakpoint t(14;18)Brian A McCarthy, Erin Boyle, Xue Ping Wang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2026
A Phase 2 Feasibility Study Combining Pembrolizumab and Metformin in patients with Metastatic Head and Neck CancerOlga Zamulko, Sam Nusbaum, Andrew Osterburg, et al.Blood|December 12, 2001
The t(8;22) in chronic myeloid leukemia fuses BCR to FGFR1: transforming activity and specific inhibition of FGFR1 fusion proteinsA Demiroglu, E J Steer, C Heath, et al.Journal of American College Health : J of ACH|June 8, 2023
A longitudinal study of SARS-CoV-2 antibody seroprevalence and mitigation behaviors among college students at an Arkansas UniversityJaimi L Allen, Benjamin C Amick, Mark L Williams, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 30, 2004
Dose escalation studies of cytarabine, daunorubicin, and etoposide with and without multidrug resistance modulation with PSC-833 in untreated adults with acute myeloid leukemia younger than 60 years: final induction results of Cancer and Leukemia Group B Study 9621Jonathan E Kolitz, Stephen L George, Richard K Dodge, et al.Critical Care Medicine|August 10, 2020
Proprotein Convertase Subtilisin/Kexin Type 9 Loss-of-Function Is Detrimental to the Juvenile Host With Septic ShockMihir R Atreya, Brynne E Whitacre, Natalie Z Cvijanovich, et al.JCI Insight|April 3, 2025
TYRA-300, an FGFR3-selective inhibitor, promotes bone growth in two FGFR3-driven models of chondrodysplasiaJacqueline H Starrett, Clara Lemoine, Matthias Guillo, et al.The International Journal of Eating Disorders|June 4, 2016
Written case formulations in the treatment of anorexia nervosa: Evidence for therapeutic benefitsKarina L Allen, Caitlin B O'Hara, Savani Bartholdy, et al.Cancer Research|November 4, 2018
Activation of PP2A and Inhibition of mTOR Synergistically Reduce MYC Signaling and Decrease Tumor Growth in Pancreatic Ductal AdenocarcinomaBrittany L Allen-Petersen, Tyler Risom, Zipei Feng, et al.The Science of the Total Environment|July 5, 2023
Why humans kill animals and why we cannot avoid itBenjamin L Allen, Christopher Bobier, Stuart Dawson, et al.Pageof 211